BEIJING, Feb. 15 (Xinhua) -- Several antiviral drugs have been
applied in clinical trials against the novel coronavirus disease
(COVID-19), and some have shown fairly good clinical efficacy, according
to an official Saturday.
Chinese researchers have narrowed down their focus to a few existing
drugs, including Chloroquine Phosphate, Favipiravir and Remdesivir,
after multiple rounds of screening, said Zhang Xinmin, director of the
China National Center for Biotechnology Development under the Ministry
of Science and Technology, at a press conference on the new virus.
The researchers scanned more than 70,000 drugs or compounds through
computer simulations and in vitro enzyme activity tests, and selected
5,000 potentially effective drug candidates, Zhang said.
Then they were tested at the cellular level against the common
coronavirus infection, and about 100 drugs were chosen for further
experiments, which helped to select the final drugs for clinical trials,
Zhang said.
Inga kommentarer:
Skicka en kommentar